Last reviewed · How we verify
Placebo comparator : physiologic serum
Physiologic serum is an isotonic saline solution that maintains osmotic balance and provides hydration without pharmacological activity.
Physiologic serum is an isotonic saline solution that maintains osmotic balance and provides hydration without pharmacological activity. Used for Placebo comparator in clinical trials.
At a glance
| Generic name | Placebo comparator : physiologic serum |
|---|---|
| Sponsor | Centre Hospitalier Universitaire de Saint Etienne |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Physiologic serum (normal saline, 0.9% sodium chloride) is a non-medicated comparator used in clinical trials. It serves as an inert control to establish baseline effects and distinguish true drug efficacy from placebo response. It has no active mechanism of action beyond fluid replacement and osmotic support.
Approved indications
- Placebo comparator in clinical trials
Common side effects
Key clinical trials
- Management of Pain in Lumbar Arthrodesis (PHASE4)
- Whey Protein Supplementation and Serum Mineral Status in Elite Endurance and Power Athletes (NA)
- A Study to Find a Suitable Dose of Exl-111 for Further Research (PHASE1)
- Effect and Tolerance of Botulinum A Toxin Rectal Injections on Fecal Incontinence (PHASE3)
- Beta Agonist Nebulization in Non Invasively Ventilated COPD Patients: Safety, and Therapeutic Efficacy Range. (PHASE2)
- Botulinum Toxin Injection in the UES for R-CPD (PHASE4)
- Meniscal INfiltration of Corticosteroid Guided With Ultra Sonography (PHASE3)
- Effect of Lidocaine-Dexmedetomidine on Pain, Inflammation, and Oxidative Stress After Bariatric Surgery. (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: